fibrinogen has been researched along with Brain Neoplasms in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (47.46) | 18.7374 |
| 1990's | 1 (1.69) | 18.2507 |
| 2000's | 4 (6.78) | 29.6817 |
| 2010's | 17 (28.81) | 24.3611 |
| 2020's | 9 (15.25) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, R; Baschin, M; Kohlmann, T; Marx, S; Paland, H; Rauch, B; Schroeder, HWS | 1 |
| Chen, L; Du, ZY; Hu, J; Wu, BW; Wu, G; Xi, CH; Yang, L; Yao, HJ; Yu, C; Yuan, Q | 1 |
| Heimberger, A; Li, S; Rao, G; Zhang, S | 1 |
| Liang, C; Niu, C; Wei, T; Zhang, T | 1 |
| Du, Y; Song, Z; Wang, Y; Yuan, Y; Zhang, Z | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| He, J; Wang, X; Xiao, R; Yao, H; Zhang, W; Zuo, W | 1 |
| Heimberger, AB; Li, S; Ott, M; Rao, G; Tian, X; Wang, J; Xia, X; Yan, J; Zhao, Q | 1 |
| Bellail, A; Bose, P; Dzikowski, L; Hao, C; Kumar, M; Mirzaei, R; Sarkar, S; Yong, VW | 1 |
| Feng, C; Gao, L; Guo, X; Wang, Q; Wang, Z; Wu, Y; Xing, B; Xu, Z; Yang, Y; Zhang, F | 1 |
| Bettinardi, N; Campanella, R; Caroli, M; Gaudino, C; Guarnaccia, L; La Verde, N; Locatelli, M; Marfia, G; Navone, SE; Rampini, P; Riboni, L | 1 |
| Davis, RE; Gabrusiewicz, K; Heimberger, AB; Huo, L; Kong, LY; Li, S; Ott, M; Rao, G; Sun, SC; Wang, J; Watowich, SS; Xia, X; Xu, J; Yan, J; Zhao, Q | 1 |
| Heimberger, AB; Latha, K; Li, S; Patel, R; Rao, G; Traylor, JI | 1 |
| Cai, L; Rong, TH; Su, XD; Wen, YS; Zhang, LJ; Zhang, XW; Zhu, JF | 1 |
| Fend, F; Goodman, SL; Klein, A; Meyermann, R; Schittenhelm, J; Sipos, B; Tatagiba, MS | 1 |
| Baaj, AA; Hussaini, S; Lemole, GM; Matika, RW; Nielsen, VG; Steinbrenner, EB; Weinand, ME | 1 |
| de Vries, EG; Hospers, GA; Mäkelburg, AB; Schröder, CP; van den Brom, RR | 1 |
| Dibra, D; Gabrusiewicz, K; Heimberger, AB; Hu, J; Kong, LY; Li, S; Xia, X; Yan, J | 1 |
| Göhre, F; Hernesniemi, J; Kivelev, J; Niemelä, M | 1 |
| Jia, Y; Pan, Y; Wang, X; Wang, Y; Wei, N; Yuan, G; Zhang, J; Zhang, K; Zhang, X; Zhang, Y; Zhao, B | 1 |
| Dai, X; Lan, Q; Ma, C; Xu, T | 1 |
| Kitayama, J; Nagawa, H; Taguri, M; Yamashita, H | 1 |
| Bock, HC; Cohnen, J; Giese, A; Kantelhardt, SR; Keric, N | 1 |
| Cui, X; Meng, F; Pan, H; Sun, G; Wang, B; Zheng, D | 1 |
| Brodhun, M; Goldbrunner, R; Handel, LL; Hanisch, UK; Heppner, F; Koch, A; Kuhn, SA; Liebmann, L; van Rossum, D; Walter, J | 1 |
| Márquez-Rivas, J; Mayorga-Buiza, MJ; Rivero-Garvía, M | 1 |
| Che, H; Gao, G; Guo, S; Song, J; Wang, W | 1 |
| BALE, WF; DICHIRO, G; GOODLAND, RL; LASKOWSKI, EJ; MATTHEWS, WB; SPAR, IL | 1 |
| GREEN, JP | 1 |
| Eliceiri, BP; Kruse, CA; Lund, CV; Nguyen, MT; Owens, GC; Pakchoian, AJ; Shaterian, A | 1 |
| Burgers, PC; Charif, H; Dekker, LJ; Kros, JM; Luider, TM; Mustafa, DA; Smitt, PA; Titulaer, MK | 1 |
| Bale, WF; Corry, P; Dewey, W; Howze, J; Kubala, M; Leavens, M; Marrack, D; Spar, IL | 1 |
| Bale, WF; Dewey, WC; Harper, PV; Marrack, D; McCardle, RJ; Spar, IL | 1 |
| Matula, C; Reddy, B; Reddy, M; Saringer, W; Schöggl, A; Weigel, G | 1 |
| Anderson, M; Matthews, KB; Stuart, J | 1 |
| Dowdle, E; Wilson, EL | 1 |
| Artru, F; Convert, J; Deschamps, J; Jourdan, C; Lamy, B; Leclerc, R; Tixier, S | 1 |
| Dziegielewska, KM; Saunders, NR; Schejter, EJ; Soreq, H; Zakut, H; Zevin-Sonkin, D; Zisling, R | 1 |
| Boström, S; Holmgren, E; Jonsson, O; Lindström, B; Stigendal, L | 1 |
| Mandybur, T; Ormsby, I; Sawaya, R; Tew, JM | 1 |
| Cortés, JM; Oliva, H; Ordi Majá, J; Sarasa Corral, JL | 1 |
| Bynke, O; Hillman, J; Lassvik, C | 1 |
| Handa, H; Teraura, T; Yamamura, K; Yamashita, J; Yumitori, K | 1 |
| Fiandino, G; Iannacci, L; Lange, MM; Madon, E; Messina, M; Miniero, R; Pastore, G; Saracco, P | 1 |
| Richling, B | 1 |
| Klein, HJ; Richter, HP; Schäfer, M | 1 |
| Fukumoto, T; Inaba, Y; Matsushima, Y; Tomita, S | 1 |
| Knöringer, P | 1 |
| De Zanche, L; Tavolato, B | 1 |
| Nabeshima, S | 1 |
| Hurt, JP; Krigman, MR; Odom, MH; Perlmutt, L | 1 |
| Myśliwiec, B; Myśliwiec, M | 1 |
| Arnaud, P; Boucher, M; Chazot, G; Fontes, M; Girard, PF | 1 |
| Cardoso, MA; de Lima, JJ; Ferreira, MV; Garcia, DS | 1 |
| Hunter, R; Pitcher, PM; Reynolds, CM; Thomson, T | 1 |
| Kuhl, DE; Sanders, TP | 1 |
| Karpinskaia, VM | 1 |
| Morozov, VV | 1 |
| Spar, IL | 1 |
3 review(s) available for fibrinogen and Brain Neoplasms
| Article | Year |
|---|---|
Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors.
Topics: Animals; Brain Neoplasms; Fibrinogen; Glioma; Humans; Immunotherapy; Mice; T-Lymphocytes, Regulatory | 2023 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
Topics: Acute Disease; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Databases, Factual; Disseminated Intravascular Coagulation; Drug Administration Schedule; Fatal Outcome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Indoles; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Mutation; Pharmacovigilance; Platelet Count; Proto-Oncogene Proteins B-raf; Recurrence; S100 Calcium Binding Protein beta Subunit; Skin Neoplasms; Sulfonamides; Tumor Burden; Vemurafenib | 2015 |
1 trial(s) available for fibrinogen and Brain Neoplasms
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
56 other study(ies) available for fibrinogen and Brain Neoplasms
| Article | Year |
|---|---|
Preoperative Thrombocytosis is Not Associated with Overall Survival in 309 Glioblastoma Patients.
Topics: Aspirin; Brain Neoplasms; Fibrinogen; Glioblastoma; Humans; Prognosis; Retrospective Studies; Thrombocytosis | 2022 |
Perioperative Risk Factors Associated with Unplanned Neurological Intensive Care Unit Events Following Elective Infratentorial Brain Tumor Resection.
Topics: Blood Glucose; Brain Neoplasms; Fibrinogen; Humans; Intensive Care Units; Retrospective Studies; Risk Factors | 2022 |
Adipose‑derived stem cell‑mediated alphastatin targeting delivery system inhibits angiogenesis and tumor growth in glioma.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Glioma; Humans; Neoplastic Stem Cells; Peptides; Stem Cells | 2023 |
Identification of integrative molecular and clinical profiles of Fibrinogen-like protein 2 in gliomas using 1323 samples.
Topics: Biomarkers, Tumor; Brain Neoplasms; Fibrinogen; Glioma; Humans; Leukocytes; Macrophages; Neoplasm Grading | 2020 |
Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
Topics: Aged; Alkaline Phosphatase; Antigens, Tumor-Associated, Carbohydrate; Brain Neoplasms; CA-125 Antigen; Calcium; Carcinoembryonic Antigen; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Hemoglobins; Humans; Logistic Models; Lung; Lung Neoplasms; Male; Membrane Proteins; Middle Aged; Partial Thromboplastin Time; Predictive Value of Tests; Reference Values; Retrospective Studies; Risk Factors; ROC Curve; Sensitivity and Specificity; Tumor Burden | 2021 |
FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Movement; Chemokines, CXC; Fibrinogen; Glioma; Mice; Mice, Inbred C57BL; Myeloid Cells; Neoplastic Stem Cells; Signal Transduction; Tumor-Associated Macrophages | 2021 |
Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.
Topics: Brain; Brain Neoplasms; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Neoplastic Stem Cells; Tumor Microenvironment | 2021 |
Coagulation Alteration and Deep Vein Thrombosis in Brain Tumor Patients During the Perioperative Period.
Topics: Adult; Aged; Biomarkers; Blood Coagulation; Brain Neoplasms; Craniotomy; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Thrombophilia; Venous Thrombosis | 2018 |
Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy.
Topics: Aged; Brain Neoplasms; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Glioblastoma; Hemoglobins; Humans; Kaplan-Meier Estimate; Leukocyte Count; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Partial Thromboplastin Time; Prognosis; von Willebrand Factor | 2019 |
FGL2 promotes tumor progression in the CNS by suppressing CD103
Topics: Animals; Antigens, CD; Brain Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Dendritic Cells; Disease Progression; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Heterografts; Humans; Integrin alpha Chains; Mice; Mice, Transgenic; Neoplastic Stem Cells; Neuroglia; NF-kappa B; p38 Mitogen-Activated Protein Kinases; STAT Transcription Factors; Survival Analysis; Tumor Burden | 2019 |
Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.
Topics: Adult; Animals; Brain Neoplasms; Fibrinogen; Glioblastoma; Humans; Molecular Targeted Therapy | 2019 |
High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Fibrinogen; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Partial Thromboplastin Time; Platelet Count; Smoking; Survival Rate; Young Adult | 2014 |
Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carcinoma; Female; Fibrinogen; Fibronectins; Humans; Immunohistochemistry; Integrin alphaVbeta3; Integrins; Male; Melanoma; Prognosis; Receptors, Vitronectin; Skin Neoplasms | 2013 |
Brain tumors enhance plasmatic coagulation: the role of hemeoxygenase-1.
Topics: Adult; Aged, 80 and over; Biopsy; Blood Coagulation; Brain Neoplasms; Carbon Monoxide; Carboxyhemoglobin; Craniotomy; Female; Fibrinogen; Fibrinolytic Agents; Heme Oxygenase-1; Humans; Kinetics; Male; Middle Aged; Plasma; Thrombelastography; Up-Regulation | 2014 |
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
Topics: Adult; Aged; Analysis of Variance; Animals; Biomarkers, Tumor; Brain Neoplasms; Cell Line, Tumor; Female; Fibrinogen; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Immunologic Factors; Immunosuppression Therapy; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Middle Aged; RNA, Messenger; Survival Analysis; T-Lymphocytes, Regulatory | 2015 |
Experiences with TachoSil® in microneurosurgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebral Revascularization; Cerebrospinal Fluid Leak; Child; Child, Preschool; Craniotomy; Drug Combinations; Female; Fibrin Tissue Adhesive; Fibrinogen; Follow-Up Studies; Hemostasis, Surgical; Humans; Incidence; Intracranial Aneurysm; Length of Stay; Male; Microsurgery; Middle Aged; Operative Time; Postoperative Complications; Prospective Studies; Retrospective Studies; Thrombin; Treatment Outcome; Young Adult | 2015 |
Risk Factors for Postoperative Fibrinogen Deficiency after Surgical Removal of Intracranial Tumors.
Topics: Afibrinogenemia; Aged; Brain Neoplasms; Female; Fibrinogen; Humans; Male; Postoperative Complications; Preoperative Care; Risk Factors; Treatment Outcome | 2015 |
3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility.
Topics: Alginates; Antineoplastic Agents, Alkylating; Bioprinting; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Fibrinogen; Gelatin; Glioma; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Models, Biological; Neoplastic Stem Cells; Porosity; Printing, Three-Dimensional; Temozolomide; Tissue Scaffolds; Vascular Endothelial Growth Factor A | 2016 |
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; C-Reactive Protein; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Fibrinogen; Humans; Inflammation; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Retrospective Studies | 2009 |
Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carmustine; Cerebral Ventricle Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combinations; Drug Implants; Female; Fibrinogen; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Recurrence, Local; Postoperative Complications; Surgical Sponges; Thrombin; Tomography, X-Ray Computed; Ventriculostomy | 2011 |
Preliminary study on changes in coagulation function and component transfusion time in patients with massive hemorrhage.
Topics: Biomarkers; Blood Coagulation Tests; Blood Component Transfusion; Blood Loss, Surgical; Brain Neoplasms; Empyema, Pleural; Female; Fibrinogen; Glioma; Hemodynamics; Humans; Hypovolemia; Intraoperative Care; Male; Middle Aged; Neurosurgical Procedures; Plasma; Prospective Studies; Shock, Hemorrhagic; Thoracic Surgical Procedures; Time Factors | 2011 |
Expression of coagulation factors and their receptors in tumor tissue and coagulation factor upregulation in peripheral blood of patients with cerebral carcinoma metastases.
Topics: Adult; Aged; Antithrombin III; Blood Coagulation Factors; Brain Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Case-Control Studies; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunohistochemistry; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Receptors, Proteinase-Activated; Up-Regulation; Young Adult | 2012 |
Comment on Bock et al. Occlusion of surgical opening of the ventricular system with fibrinogen-coated collagen fleece: a case collection study. Acta Neurochir (2011) 153:533-539.
Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carmustine; Cerebral Ventricle Neoplasms; Drug Implants; Female; Fibrinogen; Glioblastoma; Humans; Male; Microsurgery; Neoplasm Recurrence, Local; Surgical Sponges; Thrombin; Ventriculostomy | 2012 |
Inhibition of xenograft human glioma tumor growth by lentivirus-mediated gene transfer of alphastatin.
Topics: Animals; Antigens, CD; Brain Neoplasms; Cadherins; Cell Line, Tumor; Cell Proliferation; Fibrinogen; Genetic Therapy; Genetic Vectors; Glioma; Human Umbilical Vein Endothelial Cells; Humans; Lentivirus; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Recombinant Proteins; Transduction, Genetic; Tumor Burden | 2013 |
'RIAF' --RADIO-IODINATED ANTI-FIBRINOGEN ENCEPHALOGRAPHY.
Topics: Brain Neoplasms; Coagulants; Fibrinogen; Hemostatics; Humans; Iodine Isotopes; Pneumoencephalography; Radioisotopes; Radionuclide Imaging | 1963 |
LOCALIZATION OF 131 I-LABELLED ANTIBODIES TO FIBRINOGEN IN HUMAN TUMORS.
Topics: Animals; Antibodies; Brain Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Fibrinogen; Humans; Iodine Isotopes; Neoplasms; Rabbits | 1964 |
Reduced glioma infiltration in Src-deficient mice.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cerebrovascular Circulation; Fibrinogen; Fluorescent Antibody Technique; Glioma; Humans; Immunohistochemistry; Mice; Mice, Knockout; Microscopy, Confocal; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; src-Family Kinases; Vascular Endothelial Growth Factor A | 2006 |
Identification of glioma neovascularization-related proteins by using MALDI-FTMS and nano-LC fractionation to microdissected tumor vessels.
Topics: Adult; Biomarkers, Tumor; Blood Vessels; Brain Neoplasms; Carrier Proteins; Chromatography, Liquid; Female; Fibrinogen; Fibronectins; Glioma; Glycoproteins; Humans; Infant; Male; Microdissection; Middle Aged; Nanotechnology; Neovascularization, Pathologic; Peptides; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2007 |
Localization of intracranial tumors. Comparative study with 131-I-labeled antibody to human fibrinogen and neohydrin-203Hg.
Topics: Antibodies; Antibody Formation; Brain Neoplasms; Chlormerodrin; Fibrinogen; Humans; Iodine Radioisotopes; Mercury Isotopes; Radionuclide Imaging | 1967 |
131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.
Topics: Antibodies; Antifibrinolytic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Isotopes; Iodine Radioisotopes; Melanoma; Neoplasms; Radionuclide Imaging; Sarcoma | 1967 |
A clinical study of a fibrinogen-based collagen fleece for dural repair in neurosurgery.
Topics: Aprotinin; Brain Diseases; Brain Neoplasms; Coated Materials, Biocompatible; Collagen; Craniotomy; Drug Combinations; Dura Mater; Fibrinogen; Follow-Up Studies; Hemostasis, Surgical; Humans; Postoperative Complications; Prosthesis Design; Prosthesis Implantation; Reoperation; Retrospective Studies; Spinal Diseases; Spinal Neoplasms; Thrombin; Treatment Outcome | 2002 |
Coagulation and fibrinolytic activity of cerebrospinal fluid.
Topics: Acute Disease; Blood Coagulation Factors; Blood-Brain Barrier; Brain Neoplasms; Factor V; Factor XI; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Plasminogen; Subarachnoid Hemorrhage | 1978 |
Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro.
Topics: Brain; Brain Neoplasms; Cell Line; Cells, Cultured; Culture Media; Epithelial Cells; Epithelium; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Indicators and Reagents; Meningeal Neoplasms; Meningioma; Neoplasms; Plasminogen; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1978 |
[Blood coagulation disorders in intracerebral hematoma caused by rupture of intracranial angioma. Incidences on hemorrhagic recurrence].
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders; Blood Coagulation Tests; Brain Neoplasms; Cerebral Hemorrhage; Child; Female; Fibrinogen; Hemangioma; Hematoma; Humans; Intracranial Arteriovenous Malformations; Male; Middle Aged; Platelet Count; Recurrence; Rupture, Spontaneous | 1990 |
Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue.
Topics: alpha 1-Antitrypsin; alpha-Fetoproteins; alpha-Macroglobulins; Animals; Autoradiography; Blood Proteins; Brain; Brain Neoplasms; Cholinesterases; Fetus; Fibrinogen; Glioma; Haptoglobins; Humans; Immunoelectrophoresis, Two-Dimensional; Meningioma; Oocytes; Protein Biosynthesis; RNA, Messenger; Transferrin; Vitamin D-Binding Protein; Xenopus laevis | 1986 |
Fibrinopeptide A and fibrinogen fragment B beta 15-42 and their relation to the operative trauma and post-operative thromboembolism in neurosurgical patients.
Topics: Brain Diseases; Brain Neoplasms; Dextrans; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Heparin; Humans; Peptide Fragments; Postoperative Complications; Spine; Thromboembolism | 1987 |
Antifibrinolytic therapy of experimentally grown malignant brain tumors.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Brain Neoplasms; Fibrinogen; Glioblastoma; Mice; Mice, Nude; Neoplasm Transplantation | 1986 |
[Fibrolamellar hepatocarcinoma with a long clinical course and possible production of fibrinogen].
Topics: Brain Neoplasms; Carcinoma, Hepatocellular; Female; Fibrinogen; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged | 1986 |
Does peroperative external pneumatic leg muscle compression prevent post-operative venous thrombosis in neurosurgery?
Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Female; Fibrinogen; Humans; Intraoperative Care; Iodine Radioisotopes; Leg; Male; Middle Aged; Muscles; Postoperative Complications; Pressure; Radionuclide Imaging; Thrombophlebitis | 1987 |
Metastatic brain tumour and fibrinopeptides.
Topics: Adult; Aged; Brain Neoplasms; Female; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Fibrinopeptide B; Follow-Up Studies; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Urokinase-Type Plasminogen Activator | 1987 |
Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Antithrombins; Asparaginase; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Female; Fibrinogen; Hemostasis; Humans; Infant; Leukemia, Lymphoid; Male; Methotrexate; Partial Thromboplastin Time; Platelet Count; Prednisone; Prospective Studies; Prothrombin Time; Reference Values; Thrombin Time; Vincristine | 1986 |
[Preoperative endovascular embolization with homologous fibrin].
Topics: Brain Neoplasms; Carotid Artery Diseases; Combined Modality Therapy; Drug Combinations; Embolization, Therapeutic; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Intracranial Arteriovenous Malformations; Thrombin | 1985 |
[Fibrin glue in neurosurgery. Areas of use and experiences].
Topics: Brain Neoplasms; Cerebral Hemorrhage; Drug Combinations; Factor XIII; Fibrin Tissue Adhesive; Fibrinogen; Humans; Microsurgery; Thrombin; Tissue Adhesives | 1985 |
[The use of fibrin glue in neurosurgical operations].
Topics: Adolescent; Adult; Aged; Brain; Brain Neoplasms; Cerebrovascular Disorders; Child; Drug Combinations; Drug Evaluation; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Hemostasis, Surgical; Humans; Male; Middle Aged; Thrombin; Tissue Adhesives | 1985 |
[Percutaneous fibrin gluing in subcutaneous cerebrospinal fluid fistulas following operations on the brain and spinal cord].
Topics: Adolescent; Adult; Aged; Brain Injuries; Brain Neoplasms; Cerebrospinal Fluid; Drug Combinations; Dura Mater; Factor XIII; Female; Fibrin Tissue Adhesive; Fibrinogen; Fistula; Humans; Lumbar Vertebrae; Male; Meningeal Neoplasms; Meningioma; Microsurgery; Middle Aged; Postoperative Complications; Scalp; Thrombin; Tissue Adhesives; Tomography, X-Ray Computed; Wound Healing | 1985 |
[Fibrinogen in the cerebrospinal fluid. Micro-immunoelectrophoretic study].
Topics: Brain Neoplasms; Central Nervous System Diseases; Cerebrospinal Fluid Proteins; Fibrinogen; gamma-Globulins; Humans; Immunoelectrophoresis | 1966 |
The fibrinogen-fibrin system in human intracranial tumor tissues: an immunohistological study.
Topics: Animals; Antigens; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Fibrin; Fibrinogen; Fluorescent Antibody Technique; Glioblastoma; Glioma; Humans; Immunodiffusion; Immunoelectrophoresis; Iodine Isotopes; Meningioma; Mice; Neoplasms, Experimental; Plasminogen; Rabbits; Radiometry; Radionuclide Imaging; Rats; Sarcoma, Yoshida | 1969 |
Blood clotting changes in guinea pigs with a heterologous intracranial neoplasm.
Topics: Animals; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Brain Neoplasms; Factor V; Factor VIII; Fibrinogen; Glioblastoma; Guinea Pigs; Humans; Neoplasm Transplantation; Neoplasms, Experimental; Prothrombin; Prothrombin Time; Thromboplastin; Transplantation, Heterologous | 1970 |
[Fibrinogen degradation products in cerebrospinal fluid in children].
Topics: Age Factors; Brain Neoplasms; Cerebrospinal Fluid; Child; Child, Preschool; Female; Fibrinogen; Humans; Infant; Male; Meningitis; Suppuration | 1973 |
[Search for objective criteria in the study of drugs used in cerebrovascular pathology: gamma encephalography using labelled fibrinogen].
Topics: Brain; Brain Neoplasms; Fibrinogen; Humans; Intracranial Embolism and Thrombosis; Iodine Radioisotopes; Radiography; Radionuclide Imaging | 1973 |
Localization of tumours with 131I-antifibrinogen antibodies.
Topics: Adenocarcinoma; Animals; Antibodies; Brain Neoplasms; Carcinoma, Squamous Cell; Female; Fibrinogen; Hemangioma; Humans; Iodine Radioisotopes; Liver Neoplasms; Meningioma; Neoplasms; Rabbits; Radionuclide Imaging; Tuberculosis; Uterine Cervical Neoplasms | 1973 |
Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.
Topics: Adult; Aged; Blood Pressure; Brain Diseases; Brain Neoplasms; Cerebrospinal Fluid Proteins; Cerebrovascular Disorders; Encephalitis; Female; Fibrin; Fibrinogen; Hemagglutination Inhibition Tests; Humans; Intracranial Arteriosclerosis; Male; Middle Aged | 1974 |
Selective uptake of radionuclides as a basis for tumor detection.
Topics: Antigen-Antibody Reactions; Brain Neoplasms; Capillary Permeability; Chromium; DNA; Fibrinogen; Humans; Iodine Isotopes; Liver; Liver Neoplasms; Neoplasm Metastasis; Neoplasms; Osteosarcoma; Pancreas; Phosphorus Isotopes; Radioisotopes; Radionuclide Imaging; Selenium; Spleen; Strontium Isotopes; Technetium; Thyroid Gland; Thyroid Neoplasms | 1969 |
[Dynamics of fibrinolysis and several components of blood coagulation in various disorders of cerebral circulation].
Topics: Adult; Aged; Blood Coagulation; Blood Coagulation Tests; Brain Neoplasms; Cerebral Hemorrhage; Cerebrovascular Disorders; Female; Fibrinogen; Fibrinolysis; Globulins; Heparin; Humans; Ischemic Attack, Transient; Male; Middle Aged | 1968 |
[The coagulant and anticoagulant blood systems in brain tumors of supratentorial localization].
Topics: Adult; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Coagulation Tests; Brain Neoplasms; Female; Fibrinogen; Humans; Male; Middle Aged | 1968 |
Fibrinogen and antibodies to fibrin as carrier of 131-I for cancer therapy.
Topics: Aminocaproates; Animals; Antibodies; Brain Neoplasms; Carcinoma 256, Walker; Dogs; Female; Fibrinogen; Hot Temperature; Humans; Immune Sera; Injections, Intravenous; Iodine Isotopes; Lung Neoplasms; Male; Neoplasm Metastasis; Rabbits; Radionuclide Imaging; Rats | 1965 |